Evidence supporting the use of: Vitamin E (delta-tocotrienol)
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Delta-tocotrienol, a member of the Vitamin E family, has been investigated for its potential benefits in supporting bone health and treating osteoporosis, primarily in preclinical studies. Osteoporosis is characterized by decreased bone mass and increased fracture risk. In animal models, delta-tocotrienol has demonstrated the ability to improve bone microarchitecture, increase bone mineral density, and reduce bone resorption. These effects are thought to be mediated through the inhibition of osteoclast formation and activity (cells that break down bone) and the stimulation of osteoblast activity (cells that build bone), potentially via antioxidant and anti-inflammatory mechanisms. Some studies have found that delta-tocotrienol can suppress the expression of genes involved in bone breakdown and enhance markers associated with bone formation.

However, clinical evidence in humans is limited. A few small clinical trials and pilot studies suggest a possible benefit of tocotrienols (including delta-tocotrienol) in improving bone turnover markers or slowing bone loss, but these studies are preliminary, with small sample sizes and short durations. No large, robust clinical trials have confirmed efficacy for osteoporosis treatment or prevention in humans. As such, while there is emerging scientific interest and promising preclinical data, the overall level of scientific evidence is still considered weak to moderate, and delta-tocotrienol is not widely recommended in clinical guidelines for osteoporosis management at this time.

More about Vitamin E (delta-tocotrienol)
More about Osteoporosis

Products containing Vitamin E (delta-tocotrienol)

We currently have no products on Caring Sunshine that contain this ingredient.